Truist Financial Keeps Their Buy Rating on Catalyst Pharma (CPRX)
In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report). The company’s ...
Old Dominion initiated with a Buy at Truist
Truist initiated coverage of Old Dominion (ODFL) with a Buy rating and $220 price target The company will benefit from increased weight and ...